HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with ...

1 Institute of Oncology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, China 2 Internal Medicine, The Second People’s Hospital of Nantong, Nantong, China ...

Advanced-stage hepatocellular carcinoma is currently treated with various anti-PD-(L)1 antibody-containing regimens. Now, a triplet combining the anti-TIGIT antibody tiragolumab with one of these ...

A renowned medical school whose faculty helped treat a young cancer survivor honored this week by President Donald Trump is facing potentially devastating funding cuts because of the White House.

Purpose: Diverse novel therapeutic options for hepatocellular carcinoma (HCC) have surfaced in recent years. However, it is increasingly difficult to select the optimal medication. This research aims ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

Squamous cell carcinomas are neoplasms of the squamous cells that compose most of the skin s upper layers (epidermis). They also occur in a range of tissues that include the mouth, oesophagus ...

Patients with HCC can experience either early recurrence (true tumor relapse), arising from pre-existing tumor dissemination within 2 years after treatment, or late recurrence (de novo cancer), which ...